Goldman Sachs’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5B | Buy |
|
|||||
|
2025
Q1 | $1.06B | Buy |
|
|||||
|
2024
Q4 | $861M | Sell |
|
|||||
|
2024
Q3 | $1.26B | Buy |
|
|||||
|
2024
Q2 | $1.11B | Buy |
|
|||||
|
2024
Q1 | $938M | Sell |
|
|||||
|
2023
Q4 | $907M | Sell |
|
|||||
|
2023
Q3 | $937M | Buy |
|
|||||
|
2023
Q2 | $858M | Buy |
|
|||||
|
2023
Q1 | $390M | Buy |
|
|||||
|
2022
Q4 | $424M | Buy |
|
|||||
|
2022
Q3 | $398M | Sell |
|
|||||
|
2022
Q2 | $490M | Buy |
|
|||||
|
2022
Q1 | $512M | Sell |
|
|||||
|
2021
Q4 | $905M | Buy |
|
|||||
|
2021
Q3 | $862M | Buy |
|
|||||
|
2021
Q2 | $819M | Sell |
|
|||||
|
2021
Q1 | $1.49B | Sell |
|
|||||
|
2020
Q4 | $2.27B | Buy |
|
|||||
|
2020
Q3 | $1.35B | Sell |
|
|||||
|
2020
Q2 | $1.8B | Sell |
|
|||||
|
2020
Q1 | $1.34B | Buy |
|
|||||
|
2019
Q4 | $1.01B | Buy |
|
|||||
|
2019
Q3 | $517M | Buy |
|
|||||
|
2019
Q2 | $573M | Sell |
|
|||||
|
2019
Q1 | $761M | Buy |
|
|||||
|
2018
Q4 | $481M | Sell |
|
|||||
|
2018
Q3 | $857M | Buy |
|
|||||
|
2018
Q2 | $808M | Buy |
|
|||||
|
2018
Q1 | $654M | Buy |
|
|||||
|
2017
Q4 | $482M | Buy |
|
|||||
|
2017
Q3 | $480M | Sell |
|
|||||
|
2017
Q2 | $470M | Buy |
|
|||||
|
2017
Q1 | $396M | Buy |
|
|||||
|
2016
Q4 | $295M | Sell |
|
|||||
|
2016
Q3 | $607M | Buy |
|
|||||
|
2016
Q2 | $427M | Sell |
|
|||||
|
2016
Q1 | $591M | Buy |
|
|||||
|
2015
Q4 | $640M | Sell |
|
|||||
|
2015
Q3 | $925M | Buy |
|
|||||
|
2015
Q2 | $1.1B | Buy |
|
|||||
|
2015
Q1 | $814M | Buy |
|
|||||
|
2014
Q4 | $614M | Sell |
|
|||||
|
2014
Q3 | $527M | Buy |
|
|||||
|
2014
Q2 | $419M | Buy |
|
|||||
|
2014
Q1 | $286M | Buy |
|
|||||
|
2013
Q4 | $207M | Buy |
|
|||||
|
2013
Q3 | $132M | Sell |
|
|||||
|
2013
Q2 | $110M | Buy |
|